Literature DB >> 29513302

Innate Immunity in Coronary Disease. The Role of Interleukin-12 Cytokine Family in Atherosclerosis.

Rosalinda Posadas-Sánchez1, Gilberto Vargas-Alarcón2.   

Abstract

Atherosclerosis is a chronic, progressive, and multifactorial disease modulated by genetic and environmental factors. In recent years, the paradigm that explained atherosclerosis as resulting from a complex interaction between factors not accessible to medical intervention, and modifiable risk factors has changed. In this paradigm, alterations in lipid metabolism were the pivotal concept of atherosclerosis as a chronic degenerative disease. In the last years, an increasing number of observations have shown that the innate and adaptive immune responses to lipoprotein deposition and oxidation in the arterial wall significantly influence atherosclerosis. Currently, it is well recognized that the pathogenesis of atherosclerosis and its complications involves the inflammatory process, which includes the participation of several cytokines. Besides the classic cytokines involved in this process, the role of the interleukin-12 (IL-12) family has been recently demonstrated. This review describes our current understanding about the role of the family of IL-12 in atherosclerosis considering the participation of the genes that encode these cytokines in the genetic susceptibility to developing this disease. Copyright:
© 2017 SecretarÍa de Salud.

Entities:  

Keywords:  Atherosclerosis; Genes; Genetic susceptibility; Inflammation; Interleukin 12 cytokine family

Mesh:

Substances:

Year:  2018        PMID: 29513302     DOI: 10.24875/RIC.17002335

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  3 in total

Review 1.  A myriad of roles of dendritic cells in atherosclerosis.

Authors:  Yanfang Zhao; Jing Zhang; Wenjie Zhang; Yuekang Xu
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 5.732

2.  Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation.

Authors:  Yunyan Chen; Mengfei Guo; Ding Qu; Yuping Liu; Jian Guo; Yan Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

3.  Silencing IL12p35 Promotes Angiotensin II-Mediated Abdominal Aortic Aneurysm through Activating the STAT4 Pathway.

Authors:  Lanlan Wang; Chengyun Hu; Yongfei Dong; Feibiao Dai; Yongxia Xu; Yumeng Dai; Lijie Shao; Defa Zhu
Journal:  Mediators Inflamm       Date:  2021-07-27       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.